Skip to content

OKYO Pharma Limited

OKYO

CIK 0001849296

← back to feed
Revenue (TTM)
—
FY Jul 2025
Net Income (TTM)
−$4.71M
+72.0% YoY FY Jul 2025
EPS Diluted (TTM)
−$0.20
+64.9% YoY FY Jul 2025
Gross Margin
—
FY Jul 2025
Operating Margin
—
FY Jul 2025
Net Margin
—
FY Jul 2025
Free Cash Flow (TTM)
—
FY Jul 2025
Cash
$4.6M
FY Jul 2025
Total Debt
—
FY Jul 2025
Shares Outstanding
37.61M sh
FY Jul 2025

Revenue & Net Income

EPS (Diluted)

Cash Flow

Revenue Growth (YoY)

No data available for this metric.

Balance Sheet

Cash vs Debt

Recent filings